Related Experiment Video
Updated: Feb 4, 2026
09:12
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
10.5K
Toxin release mediated by the novel autolysin Cwp19 in Clostridium difficile
Imane El Meouche1, Johann Peltier2,3
1Dunlop lab, Boston University, Boston, Massachussets, USA.
Microbial Cell (Graz, Austria)
|October 4, 2018
Summary
A novel enzyme, Cwp19, aids in secreting toxins from Clostridium difficile (C. diff) in a glucose-dependent manner. This finding suggests Cwp19 plays a role in C. diff pathogenesis and toxin release mechanisms.
Area of Science:
- Microbiology
- Bacterial Pathogenesis
- Enzymology
Background:
- Clostridium difficile is a major cause of hospital-acquired diarrhea.
- Toxins A and B are key virulence factors, but their secretion is not fully understood.
- Peptidoglycan hydrolases are involved in cell wall remodeling and lysis.
Purpose of the Study:
- To characterize the novel peptidoglycan hydrolase Cwp19 in C. difficile.
- To investigate the role of Cwp19 in C. difficile pathogenesis and toxin secretion.
Main Methods:
- Characterization of the Cwp19 enzyme.
- Investigating Cwp19's role in toxin secretion.
- Assessing glucose-dependent regulation of Cwp19 activity.
Main Results:
- Cwp19 was identified as a novel peptidoglycan hydrolase in C. difficile.
- Cwp19 mediates the secretion of C. difficile toxins.
- Toxin secretion mediated by Cwp19 is dependent on glucose availability.
Conclusions:
- Cwp19 is implicated in C. difficile pathogenesis through toxin secretion.
- Glucose metabolism influences C. difficile virulence factor release.
- Further research into peptidoglycan hydrolases is crucial for understanding C. difficile.
Related Concept Videos
01:36Types of Toxins
3.7K
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.7K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
910
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
910
01:39Receptor-mediated Endocytosis
111.0K
Overview
111.0K
01:20Receptor-mediated Endocytosis
7.9K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.9K
01:28Energy-releasing Steps of Glycolysis
146.9K
Glycolysis is divided into two phases based on whether energy is utilized or released. While the first phase consumes ATP, the second phase produces energy in the form of ATP and NADH. The energy is released over a sequence of reactions that turns G3P into pyruvate. The energy-releasing phase—steps 6-10 of glycolysis—occurs twice, once for each of the two 3-carbon sugars produced during steps 1-5 of the first phase.
The first energy-releasing step—the 6th step of glycolysis...
The first energy-releasing step—the 6th step of glycolysis...
146.9K
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.2K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.2K